Bifidobacterial β-galactosidase-mediated production of galacto-oligosaccharides: structural and preliminary functional assessments
dc.contributor.author | Ambrogi, Valentina | en |
dc.contributor.author | Bottacini, Francesca | en |
dc.contributor.author | MacSharry, John | en |
dc.contributor.author | van Breen, Justin | en |
dc.contributor.author | O’Keeffe, Ellen | en |
dc.contributor.author | Walsh, Dan | en |
dc.contributor.author | Schoemaker, Barry | en |
dc.contributor.author | Cao, Linqiu | en |
dc.contributor.author | Kuipers, Bas | en |
dc.contributor.author | Lindner, Cordula | en |
dc.contributor.author | Jimeno, Maria Luisa | en |
dc.contributor.author | Doyagüez, Elisa G. | en |
dc.contributor.author | Hernandez-Hernandez, Oswaldo | en |
dc.contributor.author | Moreno, F. Javier | en |
dc.contributor.author | Schoterman, Margriet | en |
dc.contributor.author | van Sinderen, Douwe | en |
dc.contributor.funder | FrieslandCampina | en |
dc.contributor.funder | Science Foundation Ireland | en |
dc.contributor.funder | Federation of European Microbiological Societies | en |
dc.contributor.funder | Spanish Ministry of Economy, Industry and Competitiveness | en |
dc.contributor.funder | Horizon 2020 | en |
dc.date.accessioned | 2023-11-16T15:59:19Z | |
dc.date.available | 2023-11-16T15:59:19Z | |
dc.date.issued | 2021 | en |
dc.description.abstract | In the current study the ability of four previously characterized bifidobacterial β-galactosidases (designated here as BgaA, BgaC, BgaD, and BgaE) to produce galacto-oligosaccharides (GOS) was optimized. Of these enzymes, BgaA and BgaE were found to be promising candidates for GOS production (and the corresponding GOS mixtures were called GOS-A and GOS-E, respectively) with a GOS concentration of 19.0 and 40.3% (of the initial lactose), respectively. GOS-A and GOS-E were partially purified and structurally characterized. NMR analysis revealed that the predominant (non-lactose) disaccharide was allo-lactose in both purified GOS preparations. The predominant trisaccharide in GOS-A and GOS-E was shown to be 3′-galactosyllactose, with lower levels of 6′-galactosyllactose and 4′-galactosyllactose. These three oligosaccharides have also been reported to occur in human milk. Purified GOS-A and GOS-E were shown to be able to support bifidobacterial growth similar to a commercially available GOS. In addition, GOS-E and the commercially available GOS were shown to be capable of reducing Escherichia coli adhesion to a C2BBe1 cell line. Both in vitro bifidogenic activity and reduced E. coli adhesion support the prebiotic potential of GOS-E and GOS-A. | en |
dc.description.sponsorship | Federation of European Microbiological Societies (FEMS Research Grant FEMS-RG-2016-0103); Spanish Ministry of Economy, Industry and Competitiveness (Project AGL2017-84614-C2-1-R) | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Published Version | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.articleid | 750635 | en |
dc.identifier.citation | Ambrogi, V., Bottacini, F., Mac Sharry, J., Van Breen, J., O’Keeffe, E., Walsh, D., Schoemaker, B., Cao, L., Kuipers, B., Lindner, C., Jimeno, M.L., Doyagüez, E.G., Hernandez-Hernandez, O., Moreno, F.J., Schoterman, M. and Van Sinderen, D. (2021) ‘Bifidobacterial β-galactosidase-mediated production of galacto-oligosaccharides: structural and preliminary functional assessments’, Frontiers in Microbiology, 12, 750635 (19pp). doi: 10.3389/fmicb.2021.750635 | en |
dc.identifier.doi | 10.3389/fmicb.2021.750635 | en |
dc.identifier.endpage | 19 | en |
dc.identifier.issn | 1664-302X | en |
dc.identifier.journaltitle | Frontiers in Microbiology | en |
dc.identifier.startpage | 1 | en |
dc.identifier.uri | https://hdl.handle.net/10468/15241 | |
dc.identifier.volume | 12 | en |
dc.language.iso | en | en |
dc.relation.ispartof | Frontiers in Microbiology | en |
dc.relation.project | info:eu-repo/grantAgreement/SFI/SFI Research Centres/12/RC/2273/IE/Alimentary Pharmabiotic Centre (APC) - Interfacing Food & Medicine/ | en |
dc.relation.project | info:eu-repo/grantAgreement/EC/H2020::MSCA-IF-GF/843950/EU/Glycomics of Winery Antimicrobial Yeast/GLYCO-WAY | en |
dc.rights | © 2021 Ambrogi, Bottacini, Mac Sharry, van Breen, O’Keeffe, Walsh, Schoemaker, Cao, Kuipers, Lindner, Jimeno, Doyagüez, Hernandez-Hernandez, Moreno, Schoterman and van Sinderen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. | en |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | en |
dc.subject | Bifidobacterium | en |
dc.subject | Prebiotics | en |
dc.subject | Gut microbiota | en |
dc.subject | Microbiome | en |
dc.subject | Bifidogenic | en |
dc.subject | Infant | en |
dc.subject | Oligosaccharides | en |
dc.title | Bifidobacterial β-galactosidase-mediated production of galacto-oligosaccharides: structural and preliminary functional assessments | en |
dc.type | Article (peer-reviewed) | en |
dc.type | journal-article | en |
oaire.citation.volume | 12 | en |
Files
Original bundle
1 - 2 of 2
Loading...
- Name:
- fmicb-12-750635.pdf
- Size:
- 1.89 MB
- Format:
- Adobe Portable Document Format
- Description:
- Published Version
Loading...
- Name:
- Data_Sheet_1_Bifidobacterial _-Galactosidase-Mediated Production of Galacto-Oligosaccharides_ Structural and Preliminary Functional Assessments.PDF
- Size:
- 718.13 KB
- Format:
- Adobe Portable Document Format
- Description:
- Supplementary Material
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 2.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: